Amgen Inc.
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionDeDora Capital, Inc.
Latest Disclosed Ownership7,382 shares
Latest Disclosed Value $ 2,597,207
DeDora Capital, Inc. reports 0.22% decrease in ownership of AMGN / Amgen Inc.

On April 27, 2026 - DeDora Capital, Inc. filed a 13F-HR form disclosing ownership of 7,382 shares of Amgen Inc. (MX:AMGN) valued at $2,597,207 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 22, 2026 disclosing 7,398 shares of Amgen Inc.. This represents a change in shares of -0.22% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-27 2026-03-31 13F AMGEN COM 031162100 7,382 -16 -0.22 2,597 7.27 0.6368
2026-01-22 2025-12-31 13F AMGEN COM 031162100 7,398 794 12.02 2,422 29.95 0.5732
2025-10-29 2025-09-30 13F AMGEN COM 031162100 6,604 177 2.75 1,864 3.85 0.4499
2025-07-29 2025-06-30 13F AMGEN COM 031162100 6,427 498 8.40 1,794 -2.87 0.4684
2025-05-06 2025-03-31 13F AMGEN COM 031162100 5,929 328 5.86 1,847 26.59 0.5324
2025-01-30 2024-12-31 13F AMGEN COM 031162100 5,601 165 3.04 1,460 -16.68 0.3998
2024-10-21 2024-09-30 13F AMGEN COM 031162100 5,436 76 1.42 1,752 4.60 0.4893
2024-07-17 2024-06-30 13F AMGEN COM 031162100 5,360 52 0.98 1,675 10.93 0.5145
2024-04-23 2024-03-31 13F/A-1 AMGEN COM 031162100 5,308 959 22.05 1,509 20.53 0.4805
2024-04-16 2024-03-31 13F AMGEN COM 031162100 5,308 959 1,509 0.4814
2024-01-18 2023-12-31 13F AMGEN COM 031162100 4,349 -32 -0.73 1,253 6.37 0.4397
2023-10-18 2023-09-30 13F AMGEN COM 031162100 4,381 -111 -2.47 1,177 18.05 0.4637
2023-07-24 2023-06-30 13F AMGEN COM 031162100 4,492 -259 -5.45 997 -13.15 0.3866
2023-05-11 2023-03-31 13F AMGEN COM 031162100 4,751 24 0.51 1,148 -7.49 0.4900
2023-01-19 2022-12-31 13F AMGEN COM 031162100 4,727 56 1.20 1,242 17.85 0.5894
2022-10-14 2022-09-30 13F AMGEN COM 031162100 4,671 164 3.64 1,053 -4.01 0.5479
2022-07-27 2022-06-30 13F AMGEN COM 031162100 4,507 -500 -9.99 1,097 -9.41 0.5527
2022-04-14 2022-03-31 13F AMGEN COM 031162100 5,007 5,007 1,211 0.4895
2022-01-15 2021-12-31 13F AMGEN COM 031162100 0 -4,783 -100.00 0 -100.00
2021-10-18 2021-09-30 13F AMGEN COM 031162100 4,783 84 1.79 1,017 -11.18 0.4421
2021-08-03 2021-06-30 13F AMGEN COM 031162100 4,699 -226 -4.59 1,145 -6.53 0.4991
2021-04-27 2021-03-31 13F AMGEN COM 031162100 4,925 -93 -1.85 1,225 6.15 0.5797
2021-01-29 2020-12-31 13F AMGEN COM 031162100 5,018 -376 -6.97 1,154 -15.83 0.5694
2020-10-20 2020-09-30 13F AMGEN COM 031162100 5,394 38 0.71 1,371 8.55 0.7656
2020-07-31 2020-06-30 13F AMGEN COM 031162100 5,356 -537 -9.11 1,263 5.69 0.7616
2020-05-04 2020-03-31 13F AMGEN COM 031162100 5,893 35 0.60 1,195 -15.37 0.9018
2020-02-21 2019-12-31 13F AMGEN COM 031162100 5,858 -120 -2.01 1,412 22.04 0.8504
2019-10-22 2019-09-30 13F AMGEN COM 031162100 5,978 280 4.91 1,157 10.19 0.8008
2019-08-08 2019-06-30 13F/A-1 AMGEN COM 031162100 5,698 -233 -3.93 1,050 -6.83 0.7389
2019-07-24 2019-06-30 13F AMGEN COM 031162100 5,931 0 1,127
2019-04-12 2019-03-31 13F AMGEN COM 031162100 5,931 295 5.23 1,127 2.73 0.8500
2019-01-18 2018-12-31 13F AMGEN COM 031162100 5,636 417 7.99 1,097 1.39 0.9710
2018-10-19 2018-09-30 13F AMGEN COM 031162100 5,219 -2 -0.04 1,082 12.24 0.8195
2018-07-31 2018-06-30 13F AMGEN COM 031162100 5,221 -2,264 -30.25 964 -24.45 0.7594
2018-04-16 2018-03-31 13F AMGEN COM 031162100 7,485 665 9.75 1,276 7.59 1.0374
2018-02-09 2017-12-31 13F AMGEN COM 031162100 6,820 6,820 1,186 0.9822
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.